Pages that link to "Q28379614"
Jump to navigation
Jump to search
The following pages link to Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)-9-(2-phosphonylmethoxypropyl)adenine in mice (Q28379614):
Displaying 30 items.
- Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice (Q21144657) (← links)
- Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy (Q24672068) (← links)
- An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014 (Q26771734) (← links)
- Synthesis of nucleoside phosphate and phosphonate prodrugs (Q26865400) (← links)
- Prodrugs of phosphonates and phosphates: crossing the membrane barrier (Q27005712) (← links)
- Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice (Q28472590) (← links)
- A review of nanotechnological approaches for the prophylaxis of HIV/AIDS. (Q30431343) (← links)
- Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection (Q34481359) (← links)
- Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection (Q34554493) (← links)
- Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults. (Q35791633) (← links)
- Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics (Q35817013) (← links)
- Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection (Q36018953) (← links)
- An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate (Q36173759) (← links)
- Viability of primary osteoblasts after treatment with tenofovir alafenamide: Lack of cytotoxicity at clinically relevant drug concentrations (Q36275141) (← links)
- Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing study (Q36432228) (← links)
- Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis. (Q36644606) (← links)
- Tenofovir resistance and resensitization (Q36879987) (← links)
- Prodrug and conjugate drug delivery strategies for improving HIV/AIDS therapy. (Q37780687) (← links)
- Prodrug strategies for improved efficacy of nucleoside antiviral inhibitors (Q38150184) (← links)
- Phosphinophosphonates and Their Tris-pivaloyloxymethyl Prodrugs Reveal a Negatively Cooperative Butyrophilin Activation Mechanism. (Q38715641) (← links)
- Amidate prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine as inhibitors of adenylate cyclase toxin from Bordetella pertussis (Q39074891) (← links)
- Phenotypic susceptibilities to tenofovir in a large panel of clinically derived human immunodeficiency virus type 1 isolates. (Q39651462) (← links)
- Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate (Q42037463) (← links)
- Highly convergent synthesis and antiviral activity of (E)-but-2-enyl nucleoside phosphonoamidates (Q50171127) (← links)
- Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: an in vitro study (Q59285764) (← links)
- MALDI Mass Spectrometry Imaging Reveals Heterogeneous Distribution of Tenofovir and Tenofovir Diphosphate in Colorectal Tissue of Subjects Receiving a Tenofovir-Containing Enema (Q59356168) (← links)
- Tenofovir disoproxil fumarate (Q73724737) (← links)
- Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate (Q88627916) (← links)
- Repurposing Antiviral Drugs for Orthogonal RNA-Catalyzed Labeling of RNA (Q90255400) (← links)
- Increased tenofovir monoester concentrations in patients receiving tenofovir disoproxil fumarate with ledipasvir/sofosbuvir (Q91965528) (← links)